Why the study?
Do statins reduce the progression of aortic valve stenosis in patients with calcified aortic valve disease?
Do statins reduce the progression of aortic valve stenosis in patients with calcified aortic valve disease?
This review highlights emerging evidence that statin therapy may slow the progression of calcific aortic valve stenosis, drawing parallels with atherosclerosis.
Statins may slow aortic stenosis progression; hypothesis-generating and should not yet change practice pending randomized trials.
In the Western world, calcified aortic valve stenosis is the most common form of valvular heart disease, affecting up to 3% of adults over the age of 75 years. It is a gradually progressive disease, characterized by a long asymptomatic phase that may last for several decades, followed by a short symptomatic phase associated with severe restriction of the valve orifice. Investigations on treatments for aortic valve stenosis are still in progress. Thus, it is believed that calcification of aortic valve stenosis is similar to the process of atherosclerosis that occurs in coronary artery disease. Recent studies have suggested that cholesterol lowering through the use of statins may have a salutary effect on the progression of aortic valve stenosis.
No takes yet. Share an insight, caveat, or question.
Thiago et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: